Cart
sales@molnova.com
JNJ-42253432
JNJ-42253432
Catalog No. M34298
JNJ-42253432 is an oral active P2X7 antagonist capable of penetrating the central nervous system with a pKi value of 9.1 for rat and 7.9 for human P2X7 channels.
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 193 | In Stock |
|
| 5MG | 169 | In Stock |
|
| 10MG | 256 | In Stock |
|
| 25MG | 397 | In Stock |
|
| 50MG | 523 | In Stock |
|
| 100MG | 691 | In Stock |
|
| 200MG | 918 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameJNJ-42253432
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Brian Lord, et al. Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432. J Pharmacol Exp Ther. 2014 Dec;351(3):628-41.?
molnova catalog
related products
-
PPADS tetrasodium
PPADS tetrasodiuma is a potent P2X receptor antagonist and inhibitor of the inverse mode of Na/Ca2? exchange in guinea pig airway smooth muscle and is neuroprotective against glutamate/NMDA toxicity.PPADS tetrasodiuma inhibits P2X1, P2X-2, P2X-3, and P2X- 5. 5.
-
A 438079
A 438079 is a potent, and selective antagonist of P2X7 receptor (pIC50: 6.9).
-
AZD-9056
A potent, selective, orally bioavailable P2X7 receptor antagonist; inhibits release of pro-inflammatory mediators from isolated human peripheral monocytes (IL-1β and IL-18) and human alveolar macrophages (IL-1β) with IC50 values of 10-13 nM.
